vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and G III APPAREL GROUP LTD (GIII). Click either name above to swap in a different company.
G III APPAREL GROUP LTD is the larger business by last-quarter revenue ($988.6M vs $950.5M, roughly 1.0× Astrana Health, Inc.). G III APPAREL GROUP LTD runs the higher net margin — 8.2% vs 0.7%, a 7.5% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -9.0%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-106.4M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 13.7%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
G III Apparel Group is a global fashion company that designs, sources, manufactures, markets and distributes apparel, footwear, and accessories under a range of owned and licensed well-known brands. It serves department stores, specialty retailers, and e-commerce platforms across North America, Europe, and other key global markets, catering to casual, sportswear, and premium fashion consumer segments.
ASTH vs GIII — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $988.6M |
| Net Profit | $6.6M | $80.6M |
| Gross Margin | — | 38.6% |
| Operating Margin | 1.9% | 11.4% |
| Net Margin | 0.7% | 8.2% |
| Revenue YoY | 42.9% | -9.0% |
| Net Profit YoY | 184.4% | -29.8% |
| EPS (diluted) | $0.12 | $1.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $988.6M | ||
| Q3 25 | $956.0M | $613.3M | ||
| Q2 25 | $654.8M | $583.6M | ||
| Q1 25 | $620.4M | $839.5M | ||
| Q4 24 | $665.2M | $1.1B | ||
| Q3 24 | $478.7M | $644.8M | ||
| Q2 24 | $486.3M | $609.7M | ||
| Q1 24 | $404.4M | $764.8M |
| Q4 25 | $6.6M | $80.6M | ||
| Q3 25 | $373.0K | $10.9M | ||
| Q2 25 | $9.4M | $7.8M | ||
| Q1 25 | $6.7M | $48.8M | ||
| Q4 24 | $-7.8M | $114.8M | ||
| Q3 24 | $16.1M | $24.2M | ||
| Q2 24 | $19.2M | $5.8M | ||
| Q1 24 | $14.8M | $28.9M |
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 40.8% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | — | 39.5% | ||
| Q4 24 | — | 39.8% | ||
| Q3 24 | — | 42.8% | ||
| Q2 24 | — | 42.5% | ||
| Q1 24 | — | 36.9% |
| Q4 25 | 1.9% | 11.4% | ||
| Q3 25 | 2.0% | 2.7% | ||
| Q2 25 | 3.1% | 1.5% | ||
| Q1 25 | 3.3% | 8.5% | ||
| Q4 24 | 0.1% | 15.3% | ||
| Q3 24 | 5.9% | 6.4% | ||
| Q2 24 | 6.2% | 2.2% | ||
| Q1 24 | 7.5% | 6.1% |
| Q4 25 | 0.7% | 8.2% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | 1.4% | 1.3% | ||
| Q1 25 | 1.1% | 5.8% | ||
| Q4 24 | -1.2% | 10.6% | ||
| Q3 24 | 3.4% | 3.8% | ||
| Q2 24 | 3.9% | 1.0% | ||
| Q1 24 | 3.7% | 3.8% |
| Q4 25 | $0.12 | $1.84 | ||
| Q3 25 | $0.01 | $0.25 | ||
| Q2 25 | $0.19 | $0.17 | ||
| Q1 25 | $0.14 | $1.00 | ||
| Q4 24 | $-0.14 | $2.55 | ||
| Q3 24 | $0.33 | $0.53 | ||
| Q2 24 | $0.40 | $0.12 | ||
| Q1 24 | $0.31 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $184.1M |
| Total DebtLower is stronger | — | $6.5M |
| Stockholders' EquityBook value | $779.3M | $1.8B |
| Total Assets | $2.2B | $2.8B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $184.1M | ||
| Q3 25 | $463.4M | $301.8M | ||
| Q2 25 | $342.1M | $257.8M | ||
| Q1 25 | $260.9M | $181.4M | ||
| Q4 24 | $290.8M | $104.7M | ||
| Q3 24 | $350.3M | $414.8M | ||
| Q2 24 | $327.7M | $508.4M | ||
| Q1 24 | $337.3M | $507.8M |
| Q4 25 | — | $6.5M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $213.9M | ||
| Q3 24 | — | $402.5M | ||
| Q2 24 | — | $402.7M | ||
| Q1 24 | — | $402.8M |
| Q4 25 | $779.3M | $1.8B | ||
| Q3 25 | $775.5M | $1.7B | ||
| Q2 25 | $765.5M | $1.7B | ||
| Q1 25 | $745.4M | $1.7B | ||
| Q4 24 | $712.7M | $1.6B | ||
| Q3 24 | $704.6M | $1.5B | ||
| Q2 24 | $678.9M | $1.5B | ||
| Q1 24 | $653.5M | $1.6B |
| Q4 25 | $2.2B | $2.8B | ||
| Q3 25 | $2.2B | $2.7B | ||
| Q2 25 | $1.4B | $2.4B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.3B | $2.7B | ||
| Q2 24 | $1.3B | $2.6B | ||
| Q1 24 | $1.2B | $2.7B |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.26× | ||
| Q1 24 | — | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $-97.3M |
| Free Cash FlowOCF − Capex | $-6.0M | $-106.4M |
| FCF MarginFCF / Revenue | -0.6% | -10.8% |
| Capex IntensityCapex / Revenue | 0.3% | 0.9% |
| Cash ConversionOCF / Net Profit | -0.44× | -1.21× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $367.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $-97.3M | ||
| Q3 25 | $10.0M | $75.1M | ||
| Q2 25 | $90.9M | $93.8M | ||
| Q1 25 | $16.6M | $333.4M | ||
| Q4 24 | $-10.9M | $-111.8M | ||
| Q3 24 | $34.0M | $49.3M | ||
| Q2 24 | $23.2M | $45.5M | ||
| Q1 24 | $6.0M | $361.3M |
| Q4 25 | $-6.0M | $-106.4M | ||
| Q3 25 | $7.4M | $64.7M | ||
| Q2 25 | $89.5M | $85.7M | ||
| Q1 25 | $13.6M | $323.7M | ||
| Q4 24 | $-13.5M | $-120.3M | ||
| Q3 24 | $31.7M | $38.8M | ||
| Q2 24 | $20.4M | $32.8M | ||
| Q1 24 | $5.6M | $352.3M |
| Q4 25 | -0.6% | -10.8% | ||
| Q3 25 | 0.8% | 10.6% | ||
| Q2 25 | 13.7% | 14.7% | ||
| Q1 25 | 2.2% | 38.6% | ||
| Q4 24 | -2.0% | -11.1% | ||
| Q3 24 | 6.6% | 6.0% | ||
| Q2 24 | 4.2% | 5.4% | ||
| Q1 24 | 1.4% | 46.1% |
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.3% | 1.7% | ||
| Q2 25 | 0.2% | 1.4% | ||
| Q1 25 | 0.5% | 1.2% | ||
| Q4 24 | 0.4% | 0.8% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 0.6% | 2.1% | ||
| Q1 24 | 0.1% | 1.2% |
| Q4 25 | -0.44× | -1.21× | ||
| Q3 25 | 26.69× | 6.86× | ||
| Q2 25 | 9.65× | 12.09× | ||
| Q1 25 | 2.48× | 6.83× | ||
| Q4 24 | — | -0.97× | ||
| Q3 24 | 2.11× | 2.04× | ||
| Q2 24 | 1.21× | 7.84× | ||
| Q1 24 | 0.40× | 12.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
GIII
| Proprietary Brands | $498.1M | 50% |
| Licensed Brands | $479.2M | 48% |
| Retail Segment | $45.7M | 5% |
